SARS-CoV-2-Specific T-Cell as a Potent Therapeutic Strategy against Immune Evasion of Emerging COVID-19 Variants
- Keon Il Im
- , Nayoun Kim
- , Junseok Lee
- , Ui Hyeon Oh
- , Hye Won Lee
- , Dong Gun Lee
- , Gi June Min
- , Raeseok Lee
- , Jinah Lee
- , Seungtaek Kim
- , Seok Goo Cho
- The Catholic University of Korea, College of Medicine
- Ltd.
- Institut Pasteur Korea
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations